Biofrontera (BFRI) Return on Capital Employed [ROCE] (2021 - 2026)
Biofrontera (BFRI) posted Return on Capital Employed [ROCE] of -46.42% for Q2 2026.
Powered by 
Analysis
Biofrontera (BFRI) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends
For FY2025, Biofrontera's Return on Capital Employed [ROCE] came in at -84.45%, up 47.98 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] shows a four-year change of +16.99 percentage points (FY2021 to FY2025).
- In prior years, Biofrontera's Return on Capital Employed [ROCE] was -132.43% in FY2024 (-26.07 pp), -106.36% in FY2023 (-46.73 pp), -59.64% in FY2022 (+41.81 pp) and -101.44% in FY2021.
- The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q3 2022.
- On a year-over-year basis, Return on Capital Employed [ROCE] increased in 1 of the last four quarters, with an average year-over-year change of -17.04 percentage points.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2025, with a gain of 95.27 percentage points; the weakest was Q3 2025, with a drop of 122.28 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Biofrontera | 13.21 Mn | -7.66 Mn | 9.59 Mn | -47.27% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -47.27% |
| Mar 31, 2026 | -70.58% |
| Dec 31, 2025 | -112.39% |
| Sep 30, 2025 | -337.12% |
| Mar 31, 2025 | -194.26% |
| Dec 31, 2024 | -207.66% |
| Sep 30, 2024 | -214.83% |
| Jun 30, 2024 | -137.78% |
| Mar 31, 2024 | -185.40% |
| Dec 31, 2023 | -175.38% |
| Sep 30, 2023 | -382.29% |
| Jun 30, 2023 | -166.24% |
| Mar 31, 2023 | -80.56% |
| Dec 31, 2022 | -57.80% |
| Sep 30, 2022 | -39.90% |
| Jun 30, 2022 | -74.74% |
| Mar 31, 2022 | -63.79% |
| Dec 31, 2021 | -123.22% |
API Access
Biofrontera Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=BFRI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "BFRI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=BFRI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();